Senior Research Scientist
Affiliation: NYU Abu Dhabi
Education: PhD Strasbourg University; Clinical Trial Investigator Sorbonne University
Research Areas: Drug Screening, Cell Biology, Genetics, Gene editing, C. elegans
Hala Fahs is the Research and Development specialist of the NYUAD automated high-throughput screening platform for drug discovery and genetic studies in animal models. Her research work focuses on the identification of new potential disease therapeutics, such as broad-spectrum anthelmintics, to treat parasitic worm infections. Using C. elegans as a model organism, she explores the compounds’ mode of action and studies gene function by performing genetic interaction screens, high-resolution microscopy, and CRISPR. Recently, she started investigating the use of biopesticides to fight the Red Palm Weevil pest, a major threat for the UAE palm trees. Finally, she runs outreach activities to stimulate interest in science in UAE youth.
Hala was a Clinical Project Manager for the national cohort study on the 2009 H1N1 influenza pandemic at the INSERM in Paris, where she also participated in the coordination of clinical studies (Phases I to IV). Before that, her research work in Mouse and C. elegans models focused on the understanding of the genetic and cellular basis of human diseases.
Hala holds a Clinical Trial Investigator Diploma from the Sorbonne University. She received her PhD in 2007 in Molecular and Developmental Biology from the University of Strasbourg - France. She was awarded the French Ministry of Research Fellowship and the Cancer Research Foundation Fellowship.